Cns Pharmaceuticals share price today

(CNSP)

Cns Pharmaceuticals share price is $0.11 & ₹9.35 as on 21 Dec 2024, 2.30 'hrs' IST

$0.11

Market is closed - opens 8 PM, 23 Dec 2024

View live Cns Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Cns Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Cns Pharmaceuticals. Get details on the Indian mutual funds that are investing in Cns Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Cns Pharmaceuticals's financials.

Cns Pharmaceuticals share price movements

Today's Low: $0.11
Today's High: $0.12
$0.11
4.55%
Downside
Day's Volatility :11.69%
Upside
7.49%
52 Weeks Low: $0.10
52 Weeks High: $70.00
$0.11
13.18%
Downside
52 Weeks Volatility :99.86%
Upside
99.84%

Cns Pharmaceuticals Returns

Period	Cns Pharmaceuticals Inc	Index (Russel 2000)
3 Months	-22.86%	0.0%
6 Months	-95.16%	0.0%
1 Year	-99.82%	0.0%
3 Years	-99.99%	-19.7%

Cns Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$0.11
Open	$0.105
Today's High	$0.1189
Today's Low	$0.105
Market Capitalization	$5.3M
Today's Volume	$4.6M
52 Week High	$70.0
52 Week Low	$0.0955
Revenue TTM	$0.0
EBITDA	$-16.0M
Earnings Per Share (EPS)	$-352.97
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1018.78%

How to invest in Cns Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Cns Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cns Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cns Pharmaceuticals or CNSP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cns Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cns Pharmaceuticals shares which would translate to 7.725 fractional shares of Cns Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Cns Pharmaceuticals, in just a few clicks!

Returns in Cns Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Cns Pharmaceuticals investment value today

Current value as on today

₹2,02,014

Returns

₹1,02,014

(+102.01%)

Returns from Cns Pharmaceuticals Stock

₹99,818 (false-99.82%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Cns Pharmaceuticals

-36%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Cns Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 21, 2024. -36% less investors are searching Cns Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Cns Pharmaceuticals

Geode Capital Management, LLC
0.35%
UBS Group AG
0.32%
Goldman Sachs Group Inc
0.05%
Tower Research Capital LLC
0.03%

Analyst Recommendation on Cns Pharmaceuticals

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Cns Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cns Pharmaceuticals

What analysts predicted

Upside of 354.55%

Current:

$0.11

Target:

$0.50

Insights on Cns Pharmaceuticals

Price Movement
In the last 7 days, CNSP stock has moved up by 5.0%
CNSP vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 135.3%
CNSP vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 123.0%

Cns Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Cns Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cns Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cns Pharmaceuticals Inc	-16.92%	-95.16%	-99.82%	-99.99%	-100.0%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cns Pharmaceuticals Inc	NA	NA	NA	-0.85	-10.19	-2.24	NA	-2.97
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cns Pharmaceuticals Inc	Sell	$5.3M	-100.0%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Cns Pharmaceuticals

cns pharmaceuticals, inc., a biopharmaceutical company, engages in the development of anti-cancer drug candidates for primary and metastatic cancers of the brain and central nervous system. the company's lead drug candidate is berubicin, which completed phase i clinical trial that is used for the treatment of glioblastoma multiforme. it has license agreements with houston pharmaceuticals, inc. and the university of texas m.d. anderson cancer center; and a development agreement with wpd pharmaceuticals inc. cns pharmaceuticals, inc. was founded in 2017 and is based in houston, texas.

Organization	Cns Pharmaceuticals
Employees	3
CEO	Mr. John Michael Climaco Esq., J.D.
Industry	Health Technology

Management People of Cns Pharmaceuticals

Name	Title
Mr. John Michael Climaco Esq., J.D.	CEO, President & Director
Mr. Christopher S. Downs CPA, CTP, FP&A	Chief Financial Officer
Dr. Sandra L. Silberman M.D., Ph.D.	Chief Medical Officer
Dr. Waldemar Priebe Ph.D.	Founder
Dr. Donald H. Picker Ph.D.	Chief Science Officer

Important FAQs about investing in Cns Pharmaceuticals from India :

What is Cns Pharmaceuticals share price today?

Cns Pharmaceuticals share price today stands at $0.11, Open: $0.11 ; Previous Close: $0.11 ; High: $0.12 ; Low: $0.11 ; 52 Week High: $70.00 ; 52 Week Low: $0.10. The stock opens at $0.11, after a previous close of $0.11. The stock reached a daily high of $0.12 and a low of $0.11, with a 52-week high of $70.00 and a 52-week low of $0.10.

Can Indians buy Cns Pharmaceuticals shares?

Yes, Indians can invest in the Cns Pharmaceuticals (CNSP) from India.

With INDmoney, you can buy Cns Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cns Pharmaceuticals at zero transaction cost.

How can I buy Cns Pharmaceuticals shares from India?

It is very easy to buy Cns Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cns Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Cns Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Cns Pharmaceuticals stocks?

To start investing in Cns Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.